Modern Possibilities for the Vireoretinal Interface Contrasting (Experimental Study)

The contrast agents in vitreoretinal surgery are necessary to ensure the visualization of translucent and ultra-thin membranes and vitreoretinal interface (VRI) structures, but the ideal staining agent has not been found yet.

Purpose. To investigate and compare staining properties of two vital dyes for vitreous body (VB) and vitreoretinal interface visualization: “Kenalog-40” and “Vitreocontrast”.

Patients and methods. The study was performed on 20 cadaveric eyes. After eyeball dissection with the original technology, we carried out posterior vitreous cortex separation and comparative staining of retinal fragments on the side of VB and corresponding section of the VB by “Kenalog-40” and “Vitreokontrast”. Vitreo-retinal interface samples underwent morphological analysis.

Results. In contrast to «Kenalog-40», «Vitreocontrast» enables the visualization of thin layer of VB on retina surface after splitting of cortical layers during posterior vitreous detachment induction. Upon that, the adherent particles of the “Vitreocontrast” suspension remained on the corresponding splitted fragment of the VB. After staining with “Kenalog-40”, the VB surface remained smooth, shiny, with no visible changes. The results of histological examination of the obtained retinal and VB samples confirmed the presence of VB layer on the retina surface at the site of vitreoshisis formation during the induction of posterior vitreous detachment.

Conclutions. Received data confirm the possibility of vitreoshisis formation during posterior vitreous body detachment, and demonstrate the advantages of the staining properties of the “Vitreokontrast” suspension for visualization of fine structures of vitreoretinal interface. 

1. Graham R.O., Peyman G.A. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis. Arch Ophthalmol. 1974;92(2):149–154. DOI: 10.1001/archopht.1974.01010010155016

2. Machemer R., Sugita G., Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc. 1979;77:171–80.

3. Machemer R. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture. Invest Ophthalmol Vis Sci. 1988;29(12):1771–83.

4. Шкворченко Д.О., Кислицына Н.М., Колесник С.В., Колесник А.И., Какунина С.А., Норман К.С., Крупина Е.А. Контрастирующие вещества для хромовитрэктомии. Офтальмохирургия. 2016;2(2):70–77. [Shrvorchenko D.O., Kolesnik S.V., Kislitsina N.M., Kakunina S.A., Norman K.S., Kolesnik A.I., Krupina E.A. Vital dyes for chromovitrectomy. Ophtalmosurgery=Fyodorov Journal of Ophthalmic Surgery. 2016;(2):70–77. (In Russ.)] DOI: 10.25276/0235-4160-2016-2-70-77

5. Peyman G.A., Cheema R., Conway M.D. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina. 2000;20(5):554–5.

6. Mein C.E., Flynn H.W. Recognition and removal of the posterior cortical vitreous during vitreoretinal surgery for impending macular hole. Am J Ophthalmol. 1991;111(5):611–3. http://dx.doi.org/10.1016/S0002-9394(14)73707-9

7. Matsumoto H., Yamanaka I., Hisatomi T. Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloids removal: ultrastructural analisis of the inner limitimg membrane. Retina. 2007;27(2):174–9. DOI: 10.1097/01.iae.0000237954.35359

8. Enaida H., Hata Y., Ueno A., Ishibashi T. Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina. 2003;23(6):764–70.

9. Kampougeris G., Cheema R., McPherson R., Gorman C. Safety of Triamcinolone acetonide-assisted pars plana vitrectomy in macular hole surgery. Eye (Lond). 2007;21(5):591–4. DOI: 10.1038/sj.eye.6702265

10. Horio N., Horiguchi M., Yamamoto N. Triamcinolone acetonide-assisted the internal limiting membrane peeling during idiopathic macular hole surgery. Arch. Ophthalmol. 2005;123:96–9.

11. Furino C., Micelli Ferrati T., Boscia F. Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina. 2003;23(6):771–6.

12. Narayanan R., Mungcal J.K., Kenney M.K., Seigel G.M., Kuppermann B.D. Toxicity of Triamcinolone Acetonide on Retinal Neurosensory and Pigment Epithelial Cells. Invest Ophthalmol Vis Sci. 2006;47(2):722–8. DOI: 10.1167/iovs.05-0772

13. Dyer D. Callanan D., Bochow T., Abraham P., Lambert H. M., Lee S. Y., Schneiderman T., Potts S. L., Walker T. M. Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence(r) [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy. Retina. 2009;29(1):38–45. DOI: 10.1097/IAE.0b013e318188c6e2. DOI: 10.1097/ IAE.0b013e318188c6e2

14. Lang Y., Zemel E., Miller B., Perlman I. Retinal toxicity of intravitreal kenalog in albino rabbits. Retina. 2007;27(6):778–88. DOI: 10.1097/IAE.0b013e318030c517

15. Albini T., Abd-El-Barr M., Carvounis P.E., Iyer M.N., Lakhanpal R.R., Pennesi M.E., Chevez-Barrios P., Wu S.M., Holz E.R. Long-term Retinal Toxicity of Intravitreal Commercially Available Preserved Triamcinolone Acetonide (Kenalog) in Rabbit Eyes. Invest Ophthalmol Vis Sci. 2007;48(1):390–5. DOI: 10.1167/iovs.06-0145

16. Кислицына Н. М., Новиков С. В., Беликова С. В. Применение нового контрастного вещества для визуализации структур стекловидного тела (экспериментальное исследование). Общество офтальмологов России ФГУ МНТК «Микрохирургия глаза» им. акад. С.Н. Федорова. 2010;1(1):55. [Kislitsyna N. M., Novikov S. V., Belikova S. V. The use of a new vital dye for the visualization of vitreous structures (experimental study). Russian ophtalmological society The S. Fyodorov Eye Microsurgery Federal State Institution in Russia= Obshchestvo oftal’mologov Rossii FGU MNTK “Mikrokhirurgiya glaza” im. akad. S.N. Fedorova 2010;1(1):55. (In Russ.)]

17. Кислицына Н.М., Новиков С.В., Белый Ю.А., Шацких А.В., Беликова С.В. Клинико-морфологическое исследование влияния суспензии «Витреоконтраст» на ткани глаза кроликов. Офтальмохирургия. 2011;4:59–64. [Kislitsyna N.M., Novikov S.V., Belyi Y.A., Shatskih A.V., Belikova S.V. Clinical and morphological study of the influence of “Vitreocontrast” suspension on rabbit eye tissues. Ophthalmosurgery= Fyodorov Journal of Ophthalmic Surgery 2011;4:59–64. (In Russ.)]

18. Кислицына Н.М., Колесник С.В., Новиков С.В., Колесник С.В., Веселкова М.П. Анатомо-топографические особенности задней отслойки стекловидного тела при различной витреоретинальной патологии. Современные технологии в офтальмологии. 2017;1:123–126. [Kislitsyna N. M., Kolesnik S.V., Novikov S.V., Kolesnik S.V., Veselkova M.P. Anatomical and topographic features of the posterior vitreous detachment in various vitreoretinal diseases. Modern technologies in ophthalmology in Russia=Sovremennye tekhnologii v oftal’mologii. 2017;1:123–126. (In Russ.)]